Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...

The application of this code will not result in additional payment for a billed E/M visit service. A version of this article was first published February 8, 2021, by HCPro's Revenue Cycle Advisor, a ...

On Oct. 31, CMS released the HCPCS Level II codes that go into effect Jan. 1, 2012, a set that includes 285 code additions, 48 revisions and 75 deletions compared to the previous version, according to ...

FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...

-- Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances ...

FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...

BONITA SPRINGS, Fla., April 17, 2020 /PRNewswire-PRWeb/ -- HCPCS codes are now available for Comfort Release® Tapes, Comfort Release® Bandages, Comfort Release® Bordered Transparent Films and Comfort ...

Maxiocel, Advamedica’s chitosan-based wound care dressing, gets USFDA 510(k) clearance & HCPCS codes, boosting US access for chronic & acute wound treatment. MaxioCel is a soft, sterile, single-use ...

FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...

Product-specific Q Code (Q0224) facilitates product reimbursement for PEMGARDA; corresponding M Code (M0224) defines reimbursement for product administration Reimbursement through Medicare/Medicaid ...